MedPath

M518101 phase III study in plaque psoriasis patients

Phase 3
Conditions
Plaque psoriasis
Registration Number
jRCT2080222894
Lead Sponsor
Maruho Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients diagnosed with plaque psoriasis

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Multi-center, positive controlled, randomized, double-blind, parallel-group, non-inferiority
Primary Outcome Measures
NameTimeMethod
-

severity of plaque psoriasis

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.